Phibro Animal Health Announces Quarterly Dividend of $0.12 per Share
PorAinvest
martes, 29 de julio de 2025, 4:13 pm ET1 min de lectura
PAHC--
Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. It provides essential animal health solutions and mineral nutrition products for global food production systems. The company's latest dividend declaration is a reflection of its robust financial health and growth trajectory.
In the latest quarterly report, PAHC reported strong financial results, with net sales increasing by 32% to $347.8 million and net income rising to $20.9 million. The company's performance was driven by the successful integration of the Zoetis MFA business and Phibro Forward initiatives. The Animal Health segment grew by 42%, with MFA & Other product sales up by 68%.
The company maintains a strong balance sheet with a gross leverage ratio of 3.0x and $70.4 million in cash and short-term investments. The updated FY2025 guidance projects net sales of $1.26-1.29 billion and adjusted EBITDA of $177-183 million.
Phibro Animal Health Corporation's dividend declaration is a testament to its financial stability and commitment to shareholders. The company continues to expand its reach and provide innovative solutions to maintain and enhance the health of animals.
References:
[1] https://www.stocktitan.net/news/PAHC/phibro-animal-health-corporation-declares-quarterly-7ewl7bllpydo.html
[2] https://www.marketscreener.com/news/phibro-animal-health-corporation-declares-quarterly-dividend-ce7c5fdeda8ef622
ZTS--
Phibro Animal Health Corporation declared a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock. The dividend is payable on September 24, 2025, to stockholders of record at the close of business on September 3, 2025. The company is a global diversified animal health and nutrition company that strives to be a trusted partner with livestock producers and veterinarians.
Phibro Animal Health Corporation (PAHC) has announced a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock. The dividend will be payable on September 24, 2025, to stockholders of record at the close of business on September 3, 2025. This declaration follows the company's strong financial performance and continues its commitment to shareholder value.Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. It provides essential animal health solutions and mineral nutrition products for global food production systems. The company's latest dividend declaration is a reflection of its robust financial health and growth trajectory.
In the latest quarterly report, PAHC reported strong financial results, with net sales increasing by 32% to $347.8 million and net income rising to $20.9 million. The company's performance was driven by the successful integration of the Zoetis MFA business and Phibro Forward initiatives. The Animal Health segment grew by 42%, with MFA & Other product sales up by 68%.
The company maintains a strong balance sheet with a gross leverage ratio of 3.0x and $70.4 million in cash and short-term investments. The updated FY2025 guidance projects net sales of $1.26-1.29 billion and adjusted EBITDA of $177-183 million.
Phibro Animal Health Corporation's dividend declaration is a testament to its financial stability and commitment to shareholders. The company continues to expand its reach and provide innovative solutions to maintain and enhance the health of animals.
References:
[1] https://www.stocktitan.net/news/PAHC/phibro-animal-health-corporation-declares-quarterly-7ewl7bllpydo.html
[2] https://www.marketscreener.com/news/phibro-animal-health-corporation-declares-quarterly-dividend-ce7c5fdeda8ef622

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios